Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040221 · ClinicalTrials.gov registry record · Phase 1
Trichuris Suis Ova in Autism Spectrum Disorders
A Phase 1 study of Autism, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01040221 is a Phase 1 study of Autism that has completed, run by Montefiore Medical Center. The registered enrollment target is 10 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01040221, a Phase 1 study of Autism, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder
Conditions Studied
Interventions
- DRUG Trichuris Suis Ova
Study Locations (1)
New York
- Montefiore Medical Center, Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01040221
The ClinicalTrials.gov registry entry for NCT01040221 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Trichuris Suis Ova is the first listed.
NCT01040221 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01040221 about?
NCT01040221 is a clinical study titled "Trichuris Suis Ova in Autism Spectrum Disorders". The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder
What is the current status of trial NCT01040221?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-11. Estimated completion is 2014-07.
What conditions does trial NCT01040221 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT01040221?
The interventions under investigation include: Trichuris Suis Ova (DRUG).
Who is sponsoring clinical trial NCT01040221?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040221 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
RECRUITING · Phase 1
-
An Autism Study Using Nambudripad's Food Allergy Elimination Treatments
COMPLETED · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.